EDU 35 - (INTERACTIVE) New Combinations of Radiation and Systemic Therapies in Lung Cancer: Chemotherapy, Targeted Agents and Immunotherapy

10/24/2018

7:45 AM - 9:00 AM

Location: Room 006

Session Type: Educational

1.25 AMA PRA Category 1 Credits™

1.25 CAMPEP Credits

1.50 MDCB Credits

Chair(s)

AC

Aileen Chen, MD

Dana-Farber Cancer Institute

Recent advances in radiation therapy techniques and the success of new systemic therapies, such as targeted agents and immunotherapy, have improved outcomes for many patients with lung cancer. Despite these successes, the efficacy and safety of combining radiation with newer systemic agents, including in patients receiving SBRT or hypofractionation, remain an active area of investigation.

This session will review the current state of knowledge on combining systemic agents, including chemotherapy, targeted agents, and immunotherapy, with conventional and hypofractionated radiation. The faculty will also discuss ongoing and proposed studies on this topic.

Following the session, attendees should be able to identify new systemic therapies for lung cancer, to discuss how these therapies can affect radiation planning and treatment, toxicities, and cancer outcomes, and to apply this knowledge when evaluating treatment options and making treatment decisions for their patients.

Learning Objectives:

Describe new systemic therapies being used/investigated for lung cancer patients.
Assess potential benefits and risks of combining systemic therapies (chemotherapy, targeted agents, immunotherapy) with radiation (conventional, hypofractionated).
Apply knowledge of combining systemic therapies and radiation to the care of lung cancer patients.

Presentations:

7:45 AM - 8:03 AM
Overview: Using RT with systemic therapies in lung cancer
Speaker: Aileen Chen, MD – Dana-Farber Cancer Institute
8:03 AM - 8:21 AM
Chemotherapy and hypofractionated radiation
Speaker: Jose Belderbos, MD, PhD
8:21 AM - 8:39 AM
Targeted therapies and radiation
Speaker: Billy Loo, MD, PhD – Stanford University
8:39 AM - 8:57 AM
Immunotherapy and radiation
Speaker: Bradford Perez, MD
8:57 AM - 9:00 AM
Audience Q&A
Speaker: Aileen Chen, MD – Dana-Farber Cancer Institute

Send Email for Aileen Chen

Attendees who have favorited this

Jenghwa Chang
Northwell Health
Avinash Chaurasia
Radiation Oncology Resident
National Cancer Institute
Jiayan Chen
Peking University First Hospital
M. Dolores De La Mata Moya
Chief of Radiotherapy Department
ABC Medical Center
Lohith G
Dr
Hcg Cancer Care Network
Eva Galvan
Resident Physician, Radiation Oncology
Mays Cancer Center, UT Health SA, MDACC
Martin Holzman
Radiation Oncologist
Curepoint
john kordomenos
ABS
Johannes Langendijk
Professor
University Medical Center Groningen
Hsin-Hua Lee
Kaohsiung Medical University Hospital
Ping Liao
Central South University
Ashraf Mahmoud-Ahmed
Radiation Oncologist
Cape Breton Cancer Centre
Hue Thi Hong Marley
Med Student —MS4
Duke University School of Medicine
Shwan Mohammed
Dr.
Zhianawa Cancer Center
Courtney Pollard
Dr.
Md Anderson Cancer Center
Igor Sadetskii
Sheba Medical Center
Sean Shirvani
Radiation Oncologist
Reflexion Medical
Daegan Sit
Bc Cancer Agency
Antoinet van der wel
Rif
Siran Yang
National Cancer Center/Cancer Hospital, CAMS/PUMC

EDU 35 - (INTERACTIVE) New Combinations of Radiation and Systemic Therapies in Lung Cancer: Chemotherapy, Targeted Agents and Immunotherapy

Chair(s)

Learning Objectives:

Presentations:

Aileen Chen, MD

Presentation(s):

Send Email for Aileen Chen

Assets

EDU 35 - (INTERACTIVE) New Combinations of Radiation and Systemic Therapies in Lung Cancer: Chemotherapy, Targeted Agents and Immunotherapy

Attendees who have favorited this

Please enter your access key

Send Email for EDU 35 - (INTERACTIVE) New Combinations of Radiation and Systemic Therapies in Lung Cancer: Chemotherapy, Targeted Agents and Immunotherapy